{"name":"Otsuka Australia Pharmaceutical Pty Ltd","slug":"otsuka-australia-pharmaceutical-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Subcutaneous azacitidine","genericName":"Subcutaneous azacitidine","slug":"subcutaneous-azacitidine","indication":"Treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)","status":"phase_3"}]}],"pipeline":[{"name":"Subcutaneous azacitidine","genericName":"Subcutaneous azacitidine","slug":"subcutaneous-azacitidine","phase":"phase_3","mechanism":"Azacitidine is a hypomethylating agent that works by inhibiting DNA methyltransferase enzymes, leading to increased expression of tumor suppressor genes.","indications":["Treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPMDcySmpxejQzZ0pPd2dpR3YycDFhaUg3Zmg2YW1GelAzOGQwSm9ta3NFeVVJQlFybzZKaFJIUWliLWd4ZjgwQ2c4d3dFVF9nYlJsR3VrRE1MX2IwdXNjT21wRm90SnFDTWQ3RDlnQ1hZT3pNRHFaQWE3SGFlZ1piWEFrYjFzOEhfREk4SFM3bDhlYmlKbU12TjItcWRTVDJtTXRVdXdxTVhqYzVBeGMtWG15eHF1OTJoSVIzRg?oc=5","date":"2026-03-12","type":"pipeline","source":"pearceip.law","summary":"BREAKING NEWS – Australian High Court Grants Leave to Appeal to Otsuka in PTE Dispute - pearceip.law","headline":"BREAKING NEWS – Australian High Court Grants Leave to Appeal to Otsuka in PTE Dispute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNWjBCNVdLUklJLVRZRGNKSjZWdHdpWWNnSzFpSFVBeWJ0a1VwMGJHcDlwaExYeEhnMVh3VUVQaXVfaEx3VjZnSkJwX3R4a1VHaXFLdGF0N3dOcGNlSGx4S1liQ3hDTTktOWhEVzRydEdnYS16bzRpb3dzZVFIX0o3TGg2T2s2dlVOd0VpaEFNSy04Zm5qWG41Y1huMWdYYkszenFBREN1Wl9EdEU3Y1pfSmJxb2pqNE1IVVRfQnA5UXJkTUZzVkZVNHpERWw?oc=5","date":"2026-02-28","type":"patent","source":"Dentons","summary":"Patent Term Extension in Australia: implications of Otsuka v Sun Pharma and changes in IP Australia practice - Dentons","headline":"Patent Term Extension in Australia: implications of Otsuka v Sun Pharma and changes in IP Australia practice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOTHNOQW0yWk1sVHp0aVJuNGx6NVR1NDcyVkZYaGRUWDR2eXhrZjluYmIta21sOHk4Q2RlVXZzTGk4a3lqaVh1LVE0ZndQT00tWHQzcDkzZUJDaFFoalRaOTVjaF9mSk4tRGZfVm1qRHgtR0VyTXZEVWUtdUdycjViUVI1RFhEZkFLTkVNMjhhQXNERlRNakl5OFdyTHZOTjhJZUlPT05UUWFCXzVvMVFKYlpYQzdLZDVNRElPQWw2QWRSVDRPU1hwWDdaZU9TV2dYNEhpZnR3?oc=5","date":"2025-12-23","type":"patent","source":"hsfkramer.com","summary":"Mixing it up: The end of the line for patent term extensions for formulation patents in Australia - hsfkramer.com","headline":"Mixing it up: The end of the line for patent term extensions for formulation patents in Australia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdXpkZmVGX1NqYUpudktMNnJPYmdyU1dGSWhNRUJFVGs3UDZwUU5IbjlocGRLdmRLRGY4aG9JM2I5QWJPZUU0cDVkdDA2eVJOcFplV3NsZ1p2ZlVreTljRWVORW9ZeTVQVG9ETWJOV1NuUy1FWXFOSFRXUU1MNVZ4R0U1MWNWYUZVZ1ZJeUg4RkVuYk9wcldCaTdKb091eFNZTTVnb1F5ZXlzN2M?oc=5","date":"2025-12-19","type":"patent","source":"Maddocks","summary":"Patent term extensions – A formulation is not a pharmaceutical substance - Maddocks","headline":"Patent term extensions – A formulation is not a pharmaceutical substance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQdmdheFo0eVJIM29RUURMNS1JQnhOSHR0bkFFdG51aXpDVEhYVzRmR1d4THdfZGZhWVY3THN3ZzZILXBsVUEwRzU1ejNGMUJFZ2FRTW1DbjNvOXViT040dWF4WmNpUkJOZzBKRnlPVzA3Y2JWVDVhajZGeVVzQnJtM2VjQkpJNm5fbGVaZDhxOEp5eWtTaFppaGVPaldGcVNqb0N0V0J2Qk5oQV9vVV9KUHlmbjNRY0dkQlNMYzBYbzJXcElBbUN6emhRLVp0SnBXNUJ6WHp1ZElONnVlQlF0cExyS3pCVER2bUpQXzg2a1E3bWRs?oc=5","date":"2025-12-09","type":"patent","source":"pearceip.law","summary":"The End of an Era for Pharma PTEs in AU - Full Court Excludes Formulation Patent Term Extensions in Aripiprazole (ABILIFY) Appeal - pearceip.law","headline":"The End of an Era for Pharma PTEs in AU - Full Court Excludes Formulation Patent Term Extensions in Aripiprazole (ABILIF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPaFR6dU9CNnFtd0FsY1E2RU0tRGN4dTREeU5pZ0o5NGltc0ZxX2NnbEJ5eFpXdnR5emlHMWtRSXpJYUlnM2tsUVlfTFF5N2hYUmt3SGZISGdsRjhJRzNEN0htaU5FenE5ckNYVzFGQWxQc216b0RVOTNsSUVITTFRbTZZTnpON0E4S0t5UDNDSkNaMmE4akF5eVpIMXQyc3g5TjV6bDNKX3VnRkV5TTVLeFhjYnFKWlBEbGxxVVpQOUhjQlZoYUhpVGNuNVl5UQ?oc=5","date":"2025-12-08","type":"patent","source":"Wolters Kluwer","summary":"Full Federal Court abolishes patent term extensions for pharmaceutical formulations - Wolters Kluwer","headline":"Full Federal Court abolishes patent term extensions for pharmaceutical formulations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPX085VHAwYnJDUjVscTJoS2k3Y3F6bXZSNFE5al9ral9LVXlpNDlnTDBkeGtiZGE4dzhUV2dzVFYyRmhmZ2s0OFVtRndUT3hOX1NWb2J2VG5xSkMzY05tMFRxM3dfcFdSMVBrRjZSR0lvVlp0SDJMU1Vlc05iRDlqMzBsM2haSkhlYmRTYTNxalNaRWZwbXZzSXllYk9SSDRPSnhNR2NNd1d5ejBYRnExZWtNeHRMTmdLeHJ1Ylp6a0k3MmVfQ2llMTRaaTgtNGo1MGhEV01IcGlpYnlCRkcwTmhiMzJCajRxMXVtSnk0cV8?oc=5","date":"2025-12-04","type":"patent","source":"pearceip.law","summary":"Breaking News - Formulation Patents No Longer Extensible in Australia as Pharmaceutical Patentees Prepare for PTE Shake Down - pearceip.law","headline":"Breaking News - Formulation Patents No Longer Extensible in Australia as Pharmaceutical Patentees Prepare for PTE Shake ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQUGZYVTRMVi1ObnJRY3N4NG5QNzUwWF9LWDFfWlVhT0hMUk1MaUhIZzItQjkyanVBWE5BS1ZORlhaVHNWcW9kQkhPXzk1V2FVNVlmWFVUNW1CVF93RmtTdy1yUWRZdjF3WWIwbGktZlBoNVdEcE5uQnBmSkt3cEhiYWlUUnVQZTZIU2hrcnQzZWtxUXZDTXdvbkVwenRIRVNU?oc=5","date":"2025-12-03","type":"patent","source":"Ashurst","summary":"Formulations not entitled to Australian patent term extensions - Ashurst","headline":"Formulations not entitled to Australian patent term extensions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNN2FMM21FMGUyNll0WjBuV1ppZ1IxTVh3ZTFtY1Q5aHp2Vkl1NzVuMklqTTZlWjhVc1ZJR2xlWTdLUjlQaVd3TlVwNXREUFUzYnZhbHoyMUJLOHhCOGcwOG1ZdGJteWRIWVNoaTdCQnFOX19YV0VTc3dLMU5aRng4eTBudVd2OHZZR1k3SjFHREx4bGpKQ1M5TA?oc=5","date":"2025-12-01","type":"patent","source":"lawyerly.com.au","summary":"Sun Pharma defeats appeal over Otsuka’s injectable Abilify patent - lawyerly.com.au","headline":"Sun Pharma defeats appeal over Otsuka’s injectable Abilify patent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSzhuOXBoTzJxYXhadXMxUF9Tel9LSzBRTGJodTNSb29kREVWUW1WT2IzMDFnZU5GY1ZMOGQ0ZVZNa0NsQjQ4bVhYYnd3bllGOXhpRHFOU1pvR25rTVFyZUQtby1BblZQZkFCYnVSaUd0MUpfR3BpQTh6MHNPT29QaGYwZTJnV0FieWJpOTRIVmxScE9FX0Jfd0p5SU0zdVNVYy11cUF3ZU1IQQ?oc=5","date":"2025-10-08","type":"patent","source":"Maddocks","summary":"Patent term extensions – Is the sun setting on claims limited by result? - Maddocks","headline":"Patent term extensions – Is the sun setting on claims limited by result?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOU1hkendRTHI5UXo4Y242d0owR1cwcm03c3drb3RYaElkbUNrRFc0Q1k4X3R1Q0hoVTRDSHpVMnliVFVPZzMydGZBU0lkZHE3TnJ3WjZEUVNSUXlSY2l3dEgzSUNucWFzcjFtWXFWNy1ROEZlUTVhVkVydVR6T0wtOXZOelFQcEFPMjZYQmZPODNoQzZhMjJWaTBkeGxmR3hjaEdmUWpQQWxnRi1HcUp2WE9XQ05YWGZGc3JBR09Id0JVdHdYd0JfYmRR?oc=5","date":"2025-07-04","type":"pipeline","source":"pearceip.law","summary":"Extended Release, Expeditious Rejection: Federal Court Invalidates Sun Pharma’s Aripiprazole PTE - pearceip.law","headline":"Extended Release, Expeditious Rejection: Federal Court Invalidates Sun Pharma’s Aripiprazole PTE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9GdU5KVFZNUlZWQ0kzOFNDS0NOajV2MnV2UzRsUGJpOXVNVDg3UHM1dzR4RzVZUC02TERuOVFyLWlZdTh0eUhnNG5PTUlKbGh5d29BWW5kRElZTmRhVHhoczhqMVZoOTc3Wlh2eE1LaGlqbllvUDBUdQ?oc=5","date":"2018-05-23","type":"pipeline","source":"otsuka.co.jp","summary":"Otsuka Pharmaceutical Co.,Ltd. - otsuka.co.jp","headline":"Otsuka Pharmaceutical Co.,Ltd.","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}